Quest Diagnostics
[WKN: 904533 | ISIN: US74834L1008]
Aktienkurse
168,550$ -1,95%
Echtzeit-Aktienkurs Quest Diagnostics
Bid: Ask:
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Quest Diagnostics Raises 2025 Guidance

Key PointsQ2 revenue of $2.76 billion and adjusted EPS of $2.62 beat analyst estimates.Management raised full-year 2025 guidance for both…

Quest Diagnostics Boosts Its 2025 Outlook

Quest Diagnostics (NYSE:DGX) reported its second-quarter 2025 results on July 22, achieving consolidated revenue of $2.76 billion (up 15.2% year…

BCAL Commences US Operations

BCAL Diagnostics Limited (ASX: BDX) (“BCAL” or “the Company”) is pleased to announce that it has established a North Carolina,…